13FGuru
Sign in with Google Sign in with Discord

NYSE · Industrials

WATERS CORP WAT

Waters Corporation provides analytical instruments, mass spectrometry, chromatography systems, lab software, consumables, and services. Customers include pharmaceutical, biotech, food-safety, environmental, industrial, and academic labs. The main variables are instrument demand, recurring consumables/service revenue, pharma spending, and product refresh cycles.

Sources Alpha Spread investor-relations profile alphaspread.com
Biotechnology: Laboratory Analytical Instruments

Company profile

Business mix

  • Liquid chromatography and mass spectrometry: instruments and systems used to identify, measure, and separate chemical compounds.
  • Consumables, service, and software: columns, parts, maintenance, informatics, and support create recurring revenue.
  • End markets: pharma and biotech are central, with food, environmental, industrial, and academic demand adding diversification.

Current key questions

  • Are pharma and biotech capital budgets recovering after weaker instrument demand?
  • Can consumables and service revenue stabilize margins through the instrument cycle?
  • Do new platforms and software improve replacement demand and competitive position?
Holders 4 Current sample portfolio
Public mentions 0 Videos / interviews / letters
Valuation snapshot
PE 53.06 FCF 0.73% Buyback -9.54%
2026-06-07

Current firm holders

Firm Weight Value Filing period
Fundsmith Terry Smith 7.5% $956.6M 2026-03-31
First Eagle legacy Jean-Marie Eveillard 0.6% $469.1M 2026-03-31
Viking Global Investors Andreas Halvorsen 1.0% $374.2M 2026-03-31
Oakmark / Harris Associates Bill Nygren 0.1% $86.0M 2026-03-31

Recent trading changes over the last 1 quarters

Last 1 quarters Last 2 quarters Last 3 quarters Last 4 quarters
Net buyers 3 Last 1 13F filing periods
Net reducers 2 Last 1 13F filing periods
Unchanged holders 0 Share count unchanged
Increase amount $929.2M Estimated from net added shares
Reduction amount $105.4M Estimated from net reduced shares
Net share change / base shares +76.8% +2,767,523 / 3,604,280
Fundsmith Terry Smith 1 filing periods
13F 2026-03-31 Filed 2026-05-15
Minor reduction Shares -9.7% 13F value change -$394.9M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 3,557,978 Last 1 periods -345,903 (-9.7%) Total shares 3,212,075 Value $956.6M
Viking Global Investors Andreas Halvorsen 1 filing periods
13F 2026-03-31 Filed 2026-05-15
New Shares - 13F value change +$374.2M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 0 Last 1 periods +1,256,462 (New) Total shares 1,256,462 Value $374.2M
Oakmark / Harris Associates Bill Nygren 1 filing periods
13F 2026-03-31 Filed 2026-05-15
New Shares - 13F value change +$86.0M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 0 Last 1 periods +288,712 (New) Total shares 288,712 Value $86.0M
First Eagle legacy Jean-Marie Eveillard 1 filing periods
13F 2026-03-31 Filed 2026-05-12
New Shares - 13F value change +$469.1M
Settlement As of 13F 2026-03-31 · Filed 2026-05-12
Base shares 0 Last 1 periods +1,575,187 (New) Total shares 1,575,187 Value $469.1M
Gotham Asset Management Joel Greenblatt 1 filing periods
13F 2025-06-30 Filed 2025-08-14
Minor reduction Shares -15.0% 13F value change -$3.3M
Settlement As of 13F 2025-06-30 · Filed 2025-08-14
Base shares 46,302 Last 1 periods -6,935 (-15.0%) Total shares 39,367 Value $13.7M

Recent mentions

No public mentions.